Literature DB >> 18765560

IMP3: a new and important biomarker of systemic malignancies.

Shailendra Kapoor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18765560     DOI： 10.1158/1078-0432.CCR-08-0813

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


× No keyword cloud information.
  6 in total

Review 1.  Role of 3'-untranslated region translational control in cancer development, diagnostics and treatment.

Authors:  Andrii Vislovukh; Thaiz Rivera Vargas; Anna Polesskaya; Irina Groisman
Journal:  World J Biol Chem       Date:  2014-02-26

2.  Imp3 expression in benign and malignant thyroid tumors and hyperplastic nodules.

Authors:  Sezer Kulaçoğlu; Gamze Erkılınç
Journal:  Balkan Med J       Date:  2015-01-01       Impact factor: 2.021

3.  Insulin growth factor-2 binding protein 3 (IGF2BP3) is a glioblastoma-specific marker that activates phosphatidylinositol 3-kinase/mitogen-activated protein kinase (PI3K/MAPK) pathways by modulating IGF-2.

Authors:  Ramaswamy Suvasini; Bhargava Shruti; Balaram Thota; Sridevi Vijay Shinde; Dinorah Friedmann-Morvinski; Zahid Nawaz; Krishnarao Venkatesh Prasanna; Kandavel Thennarasu; Alangar Sathyaranjandas Hegde; Arimappamagan Arivazhagan; Bangalore Ashwathnarayanarao Chandramouli; Vani Santosh; Kumaravel Somasundaram
Journal:  J Biol Chem       Date:  2011-05-25       Impact factor: 5.157

4.  Role of IGF2BP3 in trophoblast cell invasion and migration.

Authors:  W Li; D Liu; W Chang; X Lu; Y-L Wang; H Wang; C Zhu; H-Y Lin; Y Zhang; J Zhou; H Wang
Journal:  Cell Death Dis       Date:  2014-01-23       Impact factor: 8.469

5.  Acquired radioresistance in cancer associated fibroblasts is concomitant with enhanced antioxidant potential and DNA repair capacity.

Authors:  Jason D Domogauer; Sonia M de Toledo; Roger W Howell; Edouard I Azzam
Journal:  Cell Commun Signal       Date:  2021-02-26       Impact factor: 5.712

Review 6.  Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression?

Authors:  Jessica L Bell; Kristin Wächter; Britta Mühleck; Nikolaos Pazaitis; Marcel Köhn; Marcell Lederer; Stefan Hüttelmaier
Journal:  Cell Mol Life Sci       Date:  2012-10-16       Impact factor: 9.261
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.